Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma

Hepatobiliary cancer is the second leading cause of cancer death worldwide [1]. The majority ( ∼90 %) of hepatobiliary cancer is hepatocellular carcinoma (HCC) which may result in liver cirrhosis. The major risk factors are chronic infection of hepatitis B and C viruses in Asia, while chronic heavy alcohol use, obesity, and diabetes in the USA and Europe. Despite of improved HCC screening , prevention, and treatment of the risk factors, the incurrence and mortality rates continue to rise. The treatment options for patients with early-stage hepatobiliary cancer are surgery, transplantation, and/or ablation.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Original Article Source Type: research